13D Filings

Versant Venture Capital VI, L.P.

CIK

1687880

13D Filings

14

Companies

5

Latest Filing

Apr 2, 2026, 04:30 PM

Filing History
Company
% Owned
Type
Filed
Tempest Therapeutics, Inc.
TPST

1.10%

-2.60%

Amendment

Apr 2, 2026, 04:30 PM

Monte Rosa Therapeutics, Inc.
GLUE

3.40%

-1.70%

Amendment

Jan 9, 2026, 04:19 PM

Repare Therapeutics Inc.
RPTX

0.20%

Amendment

Nov 21, 2025, 08:24 PM

Monte Rosa Therapeutics, Inc.
GLUE

5.10%

Amendment

Nov 12, 2025, 04:13 PM

LENZ Therapeutics, Inc.
LENZ

3.40%

-0.70%

Amendment

Nov 10, 2025, 04:48 PM

LAVA Therapeutics N.V.

0.00%

-9.00%

Amendment

Sep 23, 2025, 04:52 PM

LENZ Therapeutics, Inc.
LENZ

4.10%

-0.80%

Amendment

Sep 22, 2025, 04:20 PM

LAVA Therapeutics N.V.

9.00%

Amendment

Sep 18, 2025, 07:08 PM

LENZ Therapeutics, Inc.
LENZ

4.90%

-0.70%

Amendment

Aug 20, 2025, 05:13 PM

Tempest Therapeutics, Inc.
TPST

3.70%

-1.10%

Amendment

Aug 13, 2025, 07:14 PM

LENZ Therapeutics, Inc.
LENZ

5.60%

-1.40%

Amendment

Jul 14, 2025, 04:50 PM

LENZ Therapeutics, Inc.
LENZ

7.00%

-0.50%

Amendment

Jun 24, 2025, 04:21 PM

LENZ Therapeutics, Inc.
LENZ

7.50%

Amendment

Jun 12, 2025, 04:49 PM

Tempest Therapeutics, Inc.
TPST

4.80%

Amendment

Feb 11, 2025, 05:58 PM

Rows:

114 of 14

1